Replimune Group, Inc.: Form 10-Q for the period ended Dec 31, 2020
Filed with the SEC on Feb 4, 2021 and accepted by EDGAR at Feb 4, 2021, 08:17 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2020-10-01 to 2020-12-31 | $14.3m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2020-04-01 to 2020-12-31 | $40.5m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2020-10-01 to 2020-12-31 | −$20.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2020-04-01 to 2020-12-31 | −$57.8m | us-gaap:OperatingIncomeLoss |
| Net income | 3 months2020-10-01 to 2020-12-31 | −$21.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2020-04-01 to 2020-12-31 | −$59.4m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2020-04-01 to 2020-12-31 | −$45.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2020-04-01 to 2020-12-31 | $1.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2020-12-31 | $324.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2020-12-31 | $499.4m | us-gaap:AssetsCurrent |
| Total assets | At period end2020-12-31 | $559.2m | us-gaap:Assets |
| Current liabilities | At period end2020-12-31 | $13.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2020-12-31 | $43.0m | us-gaap:Liabilities |
| Shareholders' equity | At period end2020-12-31 | $516.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001104659-21-011950. Last ingested by Listed: Nov 11, 2026, 01:43 ET. Listed shows no prices and gives no investment advice.